GlassScriptPhysician profile
Mallory S Sotile
NPI 1841927431
$8,651.51
in general payments reported to CMS, 2019-2025
26 companies · $3,152 in 2025
The $3,152 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $456 · 2023: $1,678 · 2024: $3,367 · 2025: $3,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,608 · Education: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,607.89 |
| Education | $588.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,640.65 | 2023-2025 | |
| Abbvie INC. | $1,419.46 | 2022-2025 | |
| Janssen Biotech, INC. | $692.59 | 2022-2025 | Tremfya, Simponi Aria, Stelara |
| Ucb, INC. | $660.61 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $603.15 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $535.44 | 2023-2025 | Dupixent |
| Incyte Corporation | $471.98 | 2023-2025 | Opzelura, Opzelura |
| Dermavant Sciences, INC. | $456.34 | 2024 | Vtama |
| Pfizer INC. | $350.97 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $309.86 | 2022-2025 | Sotyktu |
| Merz North America, INC. | $300.67 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $232.95 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $182.96 | 2022-2025 | Aklief, Nemluvio, Epsolay |
| Leo Pharma INC. | $164.80 | 2023-2025 | Adbry, Anzupgo |
| Organon LLC | $147.86 | 2025 | Vtama |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $144.72 | 2022-2024 | Otezla |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Novartis Pharmaceuticals Corporation | $53.01 | 2025 | |
| Botanix Sb INC | $41.48 | 2025 | Sofdra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.11 | 2024 | Cabtreo, Arazlo, Jublia |
| Ani Pharmaceuticals, INC. | $25.92 | 2023 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $24.26 | 2025 | |
| Mallinckrodt Hospital Products INC. | $23.93 | 2025 | Acthar |
| Verrica Pharmaceuticals INC. | $20.67 | 2023 | Ycanth |
| Almirall LLC | $14.43 | 2024 | Klisyri |
| Journey Medical Corporation | $13.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Sotile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.